Cargando…
Intracellular toxic advanced glycation end-products in cardiomyocytes may cause cardiovascular disease
Cardiovascular disease (CVD) is a lifestyle-related disease (LSRD) and one of the largest public health issues. Risk factors for CVD correlate with an excessive intake of glucose and/or fructose, which has been shown to induce the production of advanced glycation end-products (AGEs). We previously i...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375929/ https://www.ncbi.nlm.nih.gov/pubmed/30765817 http://dx.doi.org/10.1038/s41598-019-39202-5 |
_version_ | 1783395449020874752 |
---|---|
author | Takata, Takanobu Sakasai-Sakai, Akiko Ueda, Tadashi Takeuchi, Masayoshi |
author_facet | Takata, Takanobu Sakasai-Sakai, Akiko Ueda, Tadashi Takeuchi, Masayoshi |
author_sort | Takata, Takanobu |
collection | PubMed |
description | Cardiovascular disease (CVD) is a lifestyle-related disease (LSRD) and one of the largest public health issues. Risk factors for CVD correlate with an excessive intake of glucose and/or fructose, which has been shown to induce the production of advanced glycation end-products (AGEs). We previously identified AGEs derived from glyceraldehyde and named them toxic AGEs (TAGE) due to their cytotoxicities and relationship with LSRD. We also reported that extracellular TAGE in the vascular system may promote CVD and that serum TAGE levels are associated with risk factors for CVD. The mechanisms responsible for the onset and/or progression of CVD by extracellular TAGE or the above risk factors involve vascular disorders. In the present study, we revealed that rat primary cultured cardiomyocytes generated intracellular TAGE, which decreased beating rates and induced cell death. LC3-II/LC3-I, a factor of autophagy, also decreased. Although intracellular TAGE may be targets of degradation as cytotoxic proteins via autophagy, they may inhibit autophagy. Furthermore, the mechanisms by which intracellular TAGE decrease beating rates and induce cell death may involve the suppression of autophagy. The present results suggest that intracellular TAGE are generated in cardiomyocytes and directly damage them, resulting in CVD. |
format | Online Article Text |
id | pubmed-6375929 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-63759292019-02-19 Intracellular toxic advanced glycation end-products in cardiomyocytes may cause cardiovascular disease Takata, Takanobu Sakasai-Sakai, Akiko Ueda, Tadashi Takeuchi, Masayoshi Sci Rep Article Cardiovascular disease (CVD) is a lifestyle-related disease (LSRD) and one of the largest public health issues. Risk factors for CVD correlate with an excessive intake of glucose and/or fructose, which has been shown to induce the production of advanced glycation end-products (AGEs). We previously identified AGEs derived from glyceraldehyde and named them toxic AGEs (TAGE) due to their cytotoxicities and relationship with LSRD. We also reported that extracellular TAGE in the vascular system may promote CVD and that serum TAGE levels are associated with risk factors for CVD. The mechanisms responsible for the onset and/or progression of CVD by extracellular TAGE or the above risk factors involve vascular disorders. In the present study, we revealed that rat primary cultured cardiomyocytes generated intracellular TAGE, which decreased beating rates and induced cell death. LC3-II/LC3-I, a factor of autophagy, also decreased. Although intracellular TAGE may be targets of degradation as cytotoxic proteins via autophagy, they may inhibit autophagy. Furthermore, the mechanisms by which intracellular TAGE decrease beating rates and induce cell death may involve the suppression of autophagy. The present results suggest that intracellular TAGE are generated in cardiomyocytes and directly damage them, resulting in CVD. Nature Publishing Group UK 2019-02-14 /pmc/articles/PMC6375929/ /pubmed/30765817 http://dx.doi.org/10.1038/s41598-019-39202-5 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Takata, Takanobu Sakasai-Sakai, Akiko Ueda, Tadashi Takeuchi, Masayoshi Intracellular toxic advanced glycation end-products in cardiomyocytes may cause cardiovascular disease |
title | Intracellular toxic advanced glycation end-products in cardiomyocytes may cause cardiovascular disease |
title_full | Intracellular toxic advanced glycation end-products in cardiomyocytes may cause cardiovascular disease |
title_fullStr | Intracellular toxic advanced glycation end-products in cardiomyocytes may cause cardiovascular disease |
title_full_unstemmed | Intracellular toxic advanced glycation end-products in cardiomyocytes may cause cardiovascular disease |
title_short | Intracellular toxic advanced glycation end-products in cardiomyocytes may cause cardiovascular disease |
title_sort | intracellular toxic advanced glycation end-products in cardiomyocytes may cause cardiovascular disease |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375929/ https://www.ncbi.nlm.nih.gov/pubmed/30765817 http://dx.doi.org/10.1038/s41598-019-39202-5 |
work_keys_str_mv | AT takatatakanobu intracellulartoxicadvancedglycationendproductsincardiomyocytesmaycausecardiovasculardisease AT sakasaisakaiakiko intracellulartoxicadvancedglycationendproductsincardiomyocytesmaycausecardiovasculardisease AT uedatadashi intracellulartoxicadvancedglycationendproductsincardiomyocytesmaycausecardiovasculardisease AT takeuchimasayoshi intracellulartoxicadvancedglycationendproductsincardiomyocytesmaycausecardiovasculardisease |